FILTER
LATEST INTERVIEWS
Ningling Wang
MANAGING PARTNER, FINNEGAN
Finnegan in Shanghai helps Chinese companies protect and enforce their IP in the US and also helps foreign clients with patent litigation in China.
Terence Koh
EXECUTIVE DIRECTOR, SINGAPORE CHEMICAL INDUSTRY COUNCIL (SCIC)
The Singapore Chemical Industry Council (SCIC) discusses its objectives for the year.
Greg Scott
CEO, CHINABIO CONSULTING
ChinaBio morphed from being an angel investor in China to becoming a consultant for foreign compa-nies looking to enter the Chinese life science space.
Michael Niemaz
KEY ACCOUNT MANAGER AEROSPACE, MDP- MAXON MOTOR FRANCE
Maxon Motor Group is a world leader in the design and manufacture of high precision DC motors. Within the group, MDP - Maxon Motor France is specialized in the development of specific mechatronic actuators.
Brian Frenzel
PRESIDENT AND CEO, TOSK, INC.
Tosk, Inc. is a small molecule, oncology drug discovery and development company.
Conrad Bucheleres, Wei Hong & Yong Zhang
AZELIS GREATER CHINA
Azelis sources an increasing array of speciality chemicals in China and distributes across the world.
Peter Parker
MANAGING GENERAL PARTNER, BIOINNOVATION CAPITAL AND CO-FOUNDER AND DIRECTOR, LABCENTRAL
LabCental offers life science companies in Massachusetts at an early stage the facilities they need to develop
Abraham Klip Moshinsky
GENERAL DIRECTOR, UNIGEL MEXICO
Unigel Mexico laments the country’s inadequate feedstock production.
Lieven Vander Elstraeten
CEO, BERTSCHI SINGAPORE PTE LTD
Bertschi Singapore will to continue the rapid expansion of its capacity and services on Jurong Island.
David Cory
CEO, EIGER BIOPHARMACEUTICALS
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latam North and Caribbean Mining 2025 - Digital Interactive
A convergence of high-commodity prices and low valuations, on the back of a structural deficit in exploration and discoveries, has set the perfect scene for increased M&A. The leverage is particularly high for acquisitions in Latam North and the Caribbean, where stocks do not command the high premiums of tier-one jurisdictions. But M&A is only a quick fix to the global resource replenishment crisis.
A convergence of high-commodity prices and low valuations, on the back of a structural deficit in exploration and discoveries, has set the perfect scene for increased M&A. The leverage is particularly high for acquisitions in Latam North and the Caribbean, where stocks do not command the high premiums of tier-one jurisdictions. But M&A is only a quick fix to the global resource replenishment crisis.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
